Regards,

On Feb 5, 2026, at 12:59=E2=80=AFPM, TJ Bourdeau <tjphuhs@gm= ail.com> wrote:

=EF=BB=BFJoyce,

Yes I have 2 years of supervisor e= xperience and nearly a year of managerial experience. As supervisor I had 5 d= irect reports. Then the company restructured and as a manager I currently ha= ve 4 direct reports.

TJ

= On Feb 4, 2026, at 4:05=E2=80=AFPM, Joyce Barreto <jbarreto@escalatescien= ces.com> wrote:

=EF=BB=BF
Hello Timothy,
No new updates from the client, however, in the time being,= our operations manager would like to know if you have managerial or supervi= sor experience. How many people and what experience do you have?
<= br>
Cordially,

<= div style=3D"color:rgb(34,34,34)">
Joyce Barreto
Escalate Life Sciences
Administrative Assistant/Recruiter
Cell: (407) 987-7529
Office: (877) 213-7740
www.escalatesciences.com
<Es= cales Life Sciences New Logo Firma.jpg>

CONFIDENTIAL NOTICE: This may c= ontain confidential and privileged information for the sole use of the inten= ded recipient. If you have received this message in error, please notify us i= mmediately by replying to this message and deleting it from your information= system.
<= /div>

On Wed, Feb 4, 2026 at 12:43= =E2=80=AFPM TJ Bourdeau <tjphuhs@gma= il.com> wrote:
Joyce,

Just checking in if there ar= e any updates to my application or if there is any other information you nee= d from me?

Thanks,
TJ

On Jan 29, 2026, at 12:10=E2=80=AFPM, Joyc= e Barreto <jbarreto@escalatesciences.com> wrote:

=
=EF=BB=BF
Th= ank you for that information Timothy, I will be forwarding this to our o= perations manager and let you know if they request anything else or if we ca= n move forward with the secondary screening/interview.

<= /div>
Cordially,

<= i>Joyce Barreto
Escalate Life Sciences
Administ= rative Assistant/Recruiter
Cell: (407) 987-7529
Office: (877) 213-7740
www.escalatesciences.com=
<Escales Life Sciences New Logo Firma.jpg&g= t;

CONFI= DENTIAL NOTICE: This may contain confidential and privileged information for= the sole use of the intended recipient. If you have received this message i= n error, please notify us immediately by replying to this message and deleti= ng it from your information system.

On Thu, Jan 29, 2026 at 1= :30=E2=80=AFAM TJ Bourdeau <tjphuhs@gmail.com> wrote:
Joyce,

Below is my response= to your text sent on 01/28/26:

At For= mulated Solutions, I=E2=80=99ve supported GMP manufacturing operations for a= pproximately 3+ years, with direct involvement in quality oversight of contr= olled environment and aseptic-adjacent manufacturing, including nasal spray p= roduction lines.
My experien= ce includes on-floor Quality support of manufacturing operations conducted i= n controlled environments where we required the dawning and doffing of =E2=80= =9Cbunny suit=E2=80=9D gowning, where I provided IPQA and FPQA oversight dur= ing active production runs. While I was not an aseptic operator, I was respo= nsible for ensuring aseptic technique, procedural adherence, and documentati= on accuracy were maintained throughout manufacturing activities. This includ= ed line clearance verification, batch record review, real-time documentation= support, and escalation of quality concerns during production.
As I progressed into Quality Supervisor a= nd then QA Manager roles, my responsibilities expanded to include review and= approval of batch records associated with aseptic/controlled-environment st= eps, deviation investigations related to aseptic practices or documentation e= rrors, and CAPA implementation to strengthen right-first-time execution. I a= lso supported inspection readiness and participated in FDA and customer audi= t shadowing, including on-floor support and follow-up documentation.<= u>
Overall, my aseptic manufacturing e= xperience is rooted in quality governance and oversight of nasal spray manuf= acturing performed under GMP-controlled environments, with a strong focus on= compliance, documentation integrity, and risk-based decision-making during l= ive production.

Let me know if you need anything else from me,
TJ